Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Leroyer

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Thrombosis Research|June 20, 2020
Predictors of residual pulmonary vascular obstruction after pulmonary embolism: Results from a prospective cohort studyGaël Picart, Philippe Robin, Cécile Tromeur, et al.
Thrombosis and Haemostasis|January 20, 2021
The Impact of Pulmonary Vascular Obstruction on the Risk of Recurrence of Pulmonary Embolism: A French Prospective CohortCharles Orione, Cécile Tromeur, Raphael Le Mao, et al.
Research and Practice in Thrombosis and Haemostasis|July 12, 2019
Evaluation of the predictive value of the bleeding prediction score VTE-BLEED for recurrent venous thromboembolismFrederikus A Klok, Emilie Presles, Cecile Tromeur, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 30, 2020
Effectiveness and safety of dupilumab for the treatment of severe asthma in a real-life French multi-centre adult cohortClairelyne Dupin, Drifa Belhadi, Laurent Guilleminault, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 6, 2025
Long-term effectiveness and safety of dupilumab in severe asthma: A 5-year real-world multicenter studyAstrid Chauvin, Drifa Belhadi, Clairelyne Dupin, et al.
Thrombosis Research|October 8, 2023
Pulmonary embolism diagnostic strategies in patients with COPD exacerbation: Post-hoc analysis of the PEP trialGeoffroy Rambaud, Vicky Mai, Camille Motreff, et al.
Thrombosis and Haemostasis|June 24, 2019
Predictors for Residual Pulmonary Vascular Obstruction after Unprovoked Pulmonary Embolism: Implications for Clinical Practice-The PADIS-PE TrialLeela Raj, Philippe Robin, Raphael Le Mao, et al.
JAMA|January 5, 2021
Prevalence of Pulmonary Embolism Among Patients With COPD Hospitalized With Acutely Worsening Respiratory SymptomsFrancis Couturaud, Laurent Bertoletti, Jean Pastre, et al.
JAMA|July 8, 2015
Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical TrialFrancis Couturaud, Olivier Sanchez, Gilles Pernod, et al.
The American Journal of Medicine|April 26, 2020
Evaluation of Venous Thromboembolism Recurrence Scores in an Unprovoked Pulmonary Embolism Population: A Post-hoc Analysis of the PADIS-PE trialLeela Raj, Emilie Presles, Raphael Le Mao, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Thrombosis Research|June 20, 2020
Predictors of residual pulmonary vascular obstruction after pulmonary embolism: Results from a prospective cohort studyGaël Picart, Philippe Robin, Cécile Tromeur, et al.
Thrombosis and Haemostasis|January 20, 2021
The Impact of Pulmonary Vascular Obstruction on the Risk of Recurrence of Pulmonary Embolism: A French Prospective CohortCharles Orione, Cécile Tromeur, Raphael Le Mao, et al.
Research and Practice in Thrombosis and Haemostasis|July 12, 2019
Evaluation of the predictive value of the bleeding prediction score VTE-BLEED for recurrent venous thromboembolismFrederikus A Klok, Emilie Presles, Cecile Tromeur, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 30, 2020
Effectiveness and safety of dupilumab for the treatment of severe asthma in a real-life French multi-centre adult cohortClairelyne Dupin, Drifa Belhadi, Laurent Guilleminault, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 6, 2025
Long-term effectiveness and safety of dupilumab in severe asthma: A 5-year real-world multicenter studyAstrid Chauvin, Drifa Belhadi, Clairelyne Dupin, et al.
Thrombosis Research|October 8, 2023
Pulmonary embolism diagnostic strategies in patients with COPD exacerbation: Post-hoc analysis of the PEP trialGeoffroy Rambaud, Vicky Mai, Camille Motreff, et al.
Thrombosis and Haemostasis|June 24, 2019
Predictors for Residual Pulmonary Vascular Obstruction after Unprovoked Pulmonary Embolism: Implications for Clinical Practice-The PADIS-PE TrialLeela Raj, Philippe Robin, Raphael Le Mao, et al.
JAMA|January 5, 2021
Prevalence of Pulmonary Embolism Among Patients With COPD Hospitalized With Acutely Worsening Respiratory SymptomsFrancis Couturaud, Laurent Bertoletti, Jean Pastre, et al.
JAMA|July 8, 2015
Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical TrialFrancis Couturaud, Olivier Sanchez, Gilles Pernod, et al.
The American Journal of Medicine|April 26, 2020
Evaluation of Venous Thromboembolism Recurrence Scores in an Unprovoked Pulmonary Embolism Population: A Post-hoc Analysis of the PADIS-PE trialLeela Raj, Emilie Presles, Raphael Le Mao, et al.
Pageof 8